RDY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dr Reddy's Laboratories Ltd

Watchlist Manager

Watchlist

Price: 11.83 USD 0.6% Market Closed

Market Cap: $2B

	Dr Reddy's Laboratories Ltd NYSE:RDY	IN
	Pila Pharma AB F:5KC	SE
N	Nordstrom Inc SWB:NRD	US
	Embotelladora Andina SA NYSE:AKO.B	CL
	Gateley (Holdings) PLC F:5I2	UK

Profitability Summary

Dr Reddy's Laboratories Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

71% > 61%

Healthy Operating Margin

10%

Sustainable 3Y Average Operating Margin

20%

Declining Operating Margin

24% > 10%

Low Net Margin

10%

Sustainable 3Y Average Net Margin

17%

Declining Net Margin

18% > 10%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

15% > 6%

Low ROE

Positive 3Y Average ROE

Positive 3Y Average ROIC

15%

Declining ROIC

20% > 6%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.